257 related articles for article (PubMed ID: 12844341)
1. Inhibition of TNF-alpha production by pentoxifylline does not prevent endotoxin-induced decrease in serum IGF-I.
Colson A; Willems B; Thissen JP
J Endocrinol; 2003 Jul; 178(1):101-9. PubMed ID: 12844341
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
Thissen JP; Verniers J
Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
[TBL] [Abstract][Full Text] [Related]
3. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.
Wang P; Li N; Li JS; Li WQ
World J Gastroenterol; 2002 Jun; 8(3):531-6. PubMed ID: 12046086
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells.
Wolf M; Böhm S; Brand M; Kreymann G
Eur J Endocrinol; 1996 Dec; 135(6):729-37. PubMed ID: 9025720
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression.
Granado M; Martín AI; Priego T; Villanúa MA; López-Calderón A
J Endocrinol; 2006 Mar; 188(3):503-11. PubMed ID: 16522730
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats.
Priego T; Granado M; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A
J Endocrinol; 2003 Oct; 179(1):107-17. PubMed ID: 14529571
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats.
Priego T; Granado M; Martín AI; López-Calderón A; Villanúa MA
J Endocrinol; 2005 Jun; 185(3):467-76. PubMed ID: 15930173
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline protects against endotoxin-induced acute renal failure in mice.
Wang W; Zolty E; Falk S; Basava V; Reznikov L; Schrier R
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1090-5. PubMed ID: 16985210
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 1 prevents liver injury through the inhibition of TNF-alpha and iNOS induction in D-galactosamine and LPS-treated rats.
Hijikawa T; Kaibori M; Uchida Y; Yamada M; Matsui K; Ozaki T; Kamiyama Y; Nishizawa M; Okumura T
Shock; 2008 Jun; 29(6):740-7. PubMed ID: 18004231
[TBL] [Abstract][Full Text] [Related]
12. Role of ghrelin on growth hormone/insulin-like growth factor-1 axis during endotoxemia.
Faim F; Passaglia P; Batalhao M; Lacchini R; Stabile AM; Carnio EC
Growth Horm IGF Res; 2019; 48-49():36-44. PubMed ID: 31494533
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis.
Yumet G; Shumate ML; Bryant P; Lin CM; Lang CH; Cooney RN
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E472-81. PubMed ID: 12169440
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines.
Ji Q; Zhang L; Jia H; Xu J
Ann Clin Lab Sci; 2004; 34(4):427-36. PubMed ID: 15648785
[TBL] [Abstract][Full Text] [Related]
15. Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1beta in vitro.
Barreca A; Ketelslegers JM; Arvigo M; Minuto F; Thissen JP
Growth Horm IGF Res; 1998 Jun; 8(3):217-23. PubMed ID: 10984310
[TBL] [Abstract][Full Text] [Related]
16. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
Priego T; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E50-6. PubMed ID: 13129855
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha.
Fernández-Celemín L; Pasko N; Blomart V; Thissen JP
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1279-90. PubMed ID: 12388149
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
Granado M; Priego T; Martín AI; Vara E; López-Calderón A; Angeles Villanúa M
Eur J Pharmacol; 2006 Apr; 536(1-2):204-10. PubMed ID: 16545800
[TBL] [Abstract][Full Text] [Related]
19. [Growth hormone insensitivity of rats under the endotoxemic condition].
Wang P; Li N; Li J; Li W
Zhonghua Wai Ke Za Zhi; 2002 Dec; 40(12):940-4. PubMed ID: 12654216
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha and growth hormone resistance in patients with chronic liver disease.
Picardi A; Gentilucci UV; Zardi EM; Caccavo D; Petitti T; Manfrini S; Pozzilli P; Afeltra A
J Interferon Cytokine Res; 2003 May; 23(5):229-35. PubMed ID: 12804065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
